USPTO serial 88822399
ICE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 5, 2021
- Examiner
- ROSSMAN,WILLIAM M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Heidelberg, DE
Heidelberg, DE
Mannheim, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shauna M. Wertheim
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC11800 SUNRISE VALLEY DRIVE15TH FLOORRESTON, VA 20191Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary diagnostic purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of immuno-therapy, in particular in the field of immuno-oncology; scientific and technological services, namely, research and design in the field of virology; scientific and technological services, namely, research and design in the field of antiinfectives; scientific and technological services, namely, research and design in the field of neurodegenerative diseases; scientific and technological services, namely, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, namely, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial research in the field of immuno-oncology | ACTIVE | — |
| 044 | Medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immuno-oncology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Affimed GmbH
- Other trademarks owned by Affimed GmbH
- Other trademarks owned by Affimed GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ICE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 6, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 6, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 20, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 11, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 11, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 8, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 1, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 18, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Aug 14, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 11, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Aug 7, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 6, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |